Skip to main content
. 2015 Nov 12;7:345–356. doi: 10.2147/CMAR.S72775

Figure 1.

Figure 1

The dose distribution of representative volumetric modulated arc therapy plans.

Notes: (A) VMAT plans for radiotherapy to prostate; (B) VMAT plans for oropharyngeal cancer; (C) VMAT plans for radiotherapy to hepatic cancer; (D) VMAT plans for pleural mesothelioma; (E) VMAT plans for spinal cord; (F) VMAT plans for abdominal tumors.